Improvement of cognitive function by ingestion of cacao flavanol : Double-blind crossover test - Cacao flavanol test: Double-blind crossover test

Shibaura institute of technology0 sites16 target enrollmentNovember 21, 2021

Conditionsot applicable

Overview

Phase: 未知
Intervention: Not specified
Conditions: ot applicable
Sponsor: Shibaura institute of technology
Enrollment: 16
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

November 21, 2021

End Date

December 5, 2021

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Shibaura institute of technology

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1\.Those who currently suffer from any kind of disease and are undergoing drug treatment 2\.Those who have or are being treated for symptoms of dementia or other memory disorder diseases. 3\.Those who have been taking medication for the purpose of disease treatment in the past month (excluding history of headache, menstrual cramps, common cold, etc.) 4\.Those who have a history of or are currently suffering from serious disorders of the liver, kidney, heart, lungs, blood, etc. 5\.Those with comorbidities or history of comorbidities in the digestive organs 6\.Patients with severe anemia 7\.Those with food allergies (especially milk) 8\.Women: Pregnant, lactating, or planning to become pregnant during the study period 9\.Persons with alcoholism or other mental disorders 10\.Those with a smoking habit 11\.Those who may change their lifestyle during the study period 12\.Those at risk of developing seasonal allergic symptoms such as hay fever during the test period. 13\.Those who have been in the habit of taking functional foods, health foods, or supplements containing the ingredients (polyphenols) of the test foods at present or within the past three months, and those who plan to do so during the test period. 14\.Those who have been in the habit of taking drugs, functional foods, health foods, or supplements claiming to have cognitive effects at present or within the past three months. 15\.Have received hormone replacement therapy within the past 6 months. 16\.Those who have been treated with hospitalization within the past 6 months, or those who are scheduled to be hospitalized during the examination period. 17\.Those who are currently participating in other human clinical trials, and those who have been participating in other human clinical trials for less than one month. 18\.Those who have not yet completed the second dose of COVID\-19 vaccine. 19\.Others who are judged by the investigator to be inappropriate for this study.